Limitless for High Blood Pressure

Phase 2

Waitlist Available

Led By David Crowley, MD

Research Sponsored by Limitless Research Inc.

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 30

Awards & highlights

No Placebo-Only Group

Summary

This trial is testing a supplement called 'Limitless' combined with a low-carb diet in adults aged 45-65 with hypertension who are not on statin therapy. The supplement aims to improve blood flow and reduce inflammation, while the diet helps stabilize blood sugar levels.

Eligible Conditions

High Blood Pressure

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 30

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~30

This trial's timeline: 3 weeks for screening, Varies for treatment, and 30 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Changes to blood nitrate from baseline to Day 30 post-supplementation with Limitless in addition to a low carbohydrate diet

Peroxynitrite

Changes to blood pressure from baseline to Day 30 post-supplementation with Limitless in addition to a low carbohydrate diet

+3 more

Secondary study objectives

Changes to C-reactive protein from baseline to Day 30 post-supplementation with Limitless in addition to a low carbohydrate diet

Changes to C-reactive protein from pre- to 2.5-hours after acute dose supplementation with Limitless at baseline and at Day 30

Changes to L-arginine from pre- to 2.5-hours after acute dose supplementation with Limitless at baseline and at Day 30

+35 more

Other study objectives

Change in Alanine Aminotransferase After 30 day supplementation with Limitless in addition to a low carbohydrate diet

Change in Amount of Basophils After 30 day supplementation with Limitless in addition to a low carbohydrate diet

Change in Amount of Eosinophils After 30 day supplementation with Limitless in addition to a low carbohydrate diet

+26 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups

Experimental Treatment

Group I: LimitlessExperimental Treatment1 Intervention

Participants will be instructed to take Limitless capsules for 30 days starting with the first dose to be administered in clinic on Visit 2 (Day 1, Baseline). The last dose will occur in clinic on Visit 3 (Day 30). Participants will be instructed to take two capsules two hours with water after breakfast, and two capsules two hours after dinner. Do not take food after evening dose before bed. (i.e. no snacking or desserts.). If a dose is missed participants are instructed to skip that dose. Participants will be advised not to exceed four capsules daily.

Do I qualify?Apply below to find out